Improving adeno-associated vector yield in high density insect cell cultures

被引:28
|
作者
Mena, Jimmy A. [1 ]
Aucoin, Marc G. [2 ]
Montes, Johnny [1 ]
Chahal, Parminder S. [1 ]
Kamen, Amine A. [1 ]
机构
[1] Natl Res Council Canada, Anim Cell Technol Grp, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada
[2] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada
来源
JOURNAL OF GENE MEDICINE | 2010年 / 12卷 / 02期
关键词
adeno-associated virus (AAV) vectors; baculovirus; fed-batch; gene therapy; high cell density; insect cells; BACULOVIRUS EXPRESSION SYSTEM; LARGE-SCALE PRODUCTION; FED-BATCH CULTURE; GENE-TRANSFER; SUSPENSION-CULTURE; VIRAL VECTORS; SF-9; CELLS; INFECTION; VIRUS; AAV;
D O I
10.1002/jgm.1420
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Recombinant adeno-associated virus (rAAV) are the most promising vectors for gene therapy. However, large-scale rAAV production remains a challenge for the translation of rAAV-based therapeutic strategies to the clinic. The baculovirus expression vector system (BEVS) has been engineered to produce high rAAV titers in serum-free suspension cultures of insect cells. Methods The typical approach of rAAV production in BEVS has been based on a synchronous infection with three baculoviruses at high multiplicity of infection (MOI) [>3 plaque forming units (pfu)/cell]. An alternative approach is to co-infect at low MOI (0.1 pfu/cell). Both strategies (high and low MOI) were compared at a cell density of 1.0 x 10(6) cells/ml in shake-flask experiments. To increase the rAAV titer, a low MOI combined with an initial cell density at infection of 5.0 x 10(6) cells/ml, in fed-batch mode, was evaluated. Subsequently, the production strategy was validated in 3-1 bioreactor runs. Results An increase of 210% in the rAAV titer (4.7 x 10(11) enhanced transduction units/l) was observed when using low MOI, an effect primarily caused by the increase in cell density. The fed-batch approach resulted in a seven-fold increase of rAAV yield. Controlled operations in bioreactor contributed to further increase the rAAV yield (2.8 x 10(14) vector genomes/l) by 25% in comparison to the shake flask results. Conclusions This high yield production process using low MOIs and a feeding strategy successfully addresses several limitations of current rAAV production in insect cells and contributes to position the BEVS system as one of the most efficient for large-scale manufacturing of rAAV vectors. Copyright (C) 2010 John Wiley & Sons, Ltd. The copyright in Jimmy A. Mena's, Johnny Montes', Parminder S. Chahal's and Amine A. Kamen's contributions belongs to the Crown in right of Canada and such copyright material is reproduced with the permission of the Research Council of Canada.
引用
收藏
页码:157 / 167
页数:11
相关论文
共 50 条
  • [21] Chromosomal effects of adeno-associated virus vector integration
    Daniel G. Miller
    Elizabeth A. Rutledge
    David W. Russell
    Nature Genetics, 2002, 30 : 147 - 148
  • [22] Avian adeno-associated virus as an anterograde transsynaptic vector
    Ito, Tetsufumi
    Ono, Munenori
    Matsui, Ryosuke
    Watanabe, Dai
    Ohmori, Harunori
    JOURNAL OF NEUROSCIENCE METHODS, 2021, 359
  • [23] Scalable recombinant adeno-associated virus vector production in insect cells using a single baculovirus construct
    de Jong, L. A.
    van Tongeren, H. M.
    Sanders, B. P.
    van Oers, M. M.
    Pijlman, G. P.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A76 - A76
  • [24] Advances in Studies on Recombinant Adeno-associated Virus Vector
    Qiu, Yan
    Yang, Bin
    Lan, Xi
    Li, Xue-Ri
    Yin, Xiang-Ping
    Liu, Ji-Xing
    ASIAN JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2012, 7 (12): : 1255 - 1260
  • [25] Development of an adeno-associated viral vector for mucopolysaccharidosis IIIC
    O'Leary, Claire
    Antunes, Andre
    Parker, Helen
    Henckaerts, Els
    Linden, Michael
    Wilkinson, Fiona
    Pshezhetsky, Alexey
    Bigger, Brian
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S88 - S88
  • [26] Adeno-associated virus integration: virus versus vector
    R H Smith
    Gene Therapy, 2008, 15 : 817 - 822
  • [27] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Michael F. Naso
    Brian Tomkowicz
    William L. Perry
    William R. Strohl
    BioDrugs, 2017, 31 : 317 - 334
  • [28] Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
    Naso, Michael F.
    Tomkowicz, Brian
    Perry, William L., III
    Strohl, William R.
    BIODRUGS, 2017, 31 (04) : 317 - 334
  • [29] Current issues in adeno-associated viral vector production
    O-W Merten
    C Gény-Fiamma
    A M Douar
    Gene Therapy, 2005, 12 : S51 - S61
  • [30] The adeno-associated virus vector for orthopaedic gene therapy
    Schwarz, EM
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (379) : S31 - S39